Systaaq Diagnostic

Diagnostic tests allow doctors to detect if a patient has a specific disease with or without outward symptoms.   In recent days, the critical role of diagnostic tests has become abundantly clear with COVID-19, where asymptomatic people can unknowingly spread the disease to others.  By using diagnostic tests, health officials can find out who has the virus, allowing individuals to self-isolate and keep others from getting sick.   Luckily, companies like Systaaq Diagnostic (Systaaq) are working hard to make these critical tests.  

Located in Prince William County’s Science Accelerator, Systaaq was a diagnostic company long before COVID-19 was known.  Initially Systaaq made diagnostic test kits focusing on diseases like dengue and HIV.   Having received CE-IVD approval (the European equivalent to U.S. Food and Drug Administration (FDA)) its primary target was the European and the Middle East markets.   However, seeing the great need for diagnostic tests for COVID-19 here in the US and abroad, the company quickly pivoted to create a COVID-19 PCR test.  Its test allows health officials to quickly, clearly, and cost-effectively test for COVID-19.

Over the past few months, the demand for Systaaq’s COVID-19 test has grown almost exponentially, and according to company officials, working to meet the demand has been a rewarding challenge.  Today, Systaaq has the capacity to produce 400,000 tests per week and is in the process of getting FDA approval so they can start selling their tests domestically.   Approval is expected any day now, at which time, Prince William County will have its own resident company that can efficiently provide the tests it needs to support the safe reopening of the economy.   

More information can be found at


Back to Blog